Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole and fluoroquinolones in the treatment of community-acquired pyelonephritis
JavaScript is disabled for your browser. Some features of this site may not work without it.
Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole and fluoroquinolones in the treatment of community-acquired pyelonephritis
